Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

NCT07416539 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID - 19
SARS CoV-2

Interventions

BIOLOGICAL: COVID-19 Vaccines
BIOLOGICAL: COVID-19 Vaccines

Sponsor

Rokote Laboratories Finland Oy

Collaborators

Oy Medfiles Ltd
Estimates OY